Low-frequency ultrasound increases non-viral gene transfer to the mouse lung

被引:10
|
作者
Xenariou, Stefania [1 ,2 ]
Liang, Hai-Dong [3 ]
Griesenbach, Uta [1 ,2 ]
Zhu, Jie [1 ]
Farley, Raymond [1 ,2 ]
Somerton, Lucinda [1 ,2 ]
Singh, Charanjit [1 ,2 ]
Jeffery, Peter K. [1 ]
Scheule, Ronald K. [4 ]
Cheng, Seng H. [4 ]
Geddes, Duncan M. [1 ,2 ]
Blomley, Martin [3 ]
Alton, Eric W. F. W. [1 ,2 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Fac Med, Natl Heart & Lung Inst, Dept Gene Therapy, London, England
[2] UK Cyst Fibrosis Gene Therapy Consortium, London, England
[3] Univ London Imperial Coll Sci Technol & Med, Fac Med, Imaging Sci Dept, Ultrasound Grp,MRC,Clin Sci Ctr, London, England
[4] Genzyme Corp, Framingham, MA 01701 USA
关键词
low-frequency ultrasound; sonoporation; gene transfer; non-viral vector; lung; cystic fibrosis; IN-VIVO; CYSTIC-FIBROSIS; AIRWAY EPITHELIUM; NASAL EPITHELIUM; DRUG-DELIVERY; SONOPHORESIS; PLASMID; DAMAGE; EXPRESSION; DEPENDENCE;
D O I
10.1093/abbs/gmp100
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The aim of the study was to assess if low-frequency ultrasound (US), in the range of 30-35 kHz, increases non-viral gene transfer to the mouse lung. US is greatly attenuated in the lung due to large energy losses at the air/tissue interfaces. The advantages of low-frequency US, compared with high-frequency US are: (i) increased cavitation (responsible for the formation of transient pores in the cell membrane) and (ii) reduced energy losses during lung penetration. Cationic lipid GL67/plasmid DNA (pDNA), polyethylenimine (PEI)/pDNA and naked pDNA were delivered via intranasal instillation and the animals were then exposed to US (sonoporation) at 0.07 or 0.1 MPa for 10 min. Under these conditions, US did not enhance GL67 or PEI-mediated transfection. It did, however, increase naked pDNA gene transfer by approximately 4 folds. Importantly, this was achieved in the absence of microbubbles, which are crucial for the commonly used high-frequency (1 MHz) sonoporation but may not be able to withstand nebulization in a clinically relevant setup. Lung hemorrhage was also assessed and shown to increase with US pressure in a dose-dependent manner. We have thus, established that low-frequency US can enhance lung gene transfer with naked pDNA and this enhancement is more effective than the previously reported 1 MHz US.
引用
收藏
页码:45 / 51
页数:7
相关论文
共 50 条
  • [1] The role of doxorubicin in non-viral gene transfer in the lung
    Griesenbach, Uta
    Meng, Cuixiang
    Farley, Raymond
    Gardner, Aaron
    Brake, Maresa A.
    Frankel, Gad M.
    Gruenert, Dieter C.
    Cheng, Seng H.
    Scheule, Ronald K.
    Alton, Eric W. F. W.
    BIOMATERIALS, 2009, 30 (10) : 1971 - 1977
  • [2] The use of carboxymethylcellulose gel to increase non-viral gene transfer in mouse airways
    Griesenbach, Uta
    Meng, Cuixiang
    Farley, Raymond
    Wasowicz, Marguerite Y.
    Munkonge, Felix M.
    Chan, Mario
    Stoneham, Charlotte
    Sumner-Jones, Stephanie G.
    Pringle, Ian A.
    Gill, Deborah R.
    Hyde, Stephen C.
    Stevenson, Barbara
    Holder, Emma
    Ban, Hiroshi
    Hasegawa, Mamoru
    Cheng, Seng H.
    Scheule, Ronald K.
    Sinn, Patrick L.
    McCray, Paul B., Jr.
    Alton, Eric W. F. W.
    BIOMATERIALS, 2010, 31 (09) : 2665 - 2672
  • [3] Vascular gene transfer and drug delivery in vitro using low-frequency ultrasound and microbubbles
    Yang, Hong
    Liu, Zhong-hua
    Liu, Yi-yao
    Lou, Chang-chun
    Ren, Zheng-long
    Miyoshi, Hirokazu
    ACTA PHARMACOLOGICA SINICA, 2010, 31 (04) : 515 - 522
  • [4] Identification of transfected cell types following non-viral gene transfer to the murine lung
    Davies, Lee A.
    Seguela, Claire
    Varathalingam, Anusha
    Cheng, Seng H.
    Hyde, Stephen C.
    Gill, Deborah R.
    JOURNAL OF GENE MEDICINE, 2007, 9 (03): : 184 - 196
  • [5] Non-viral gene transfer therapy for cystic fibrosis
    Ziady, AG
    Davis, PB
    Konstan, NW
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2003, 3 (03) : 449 - 458
  • [6] Pre-clinical evaluation of three non-viral gene transfer agents for cystic fibrosis after aerosol delivery to the ovine lung
    McLachlan, G.
    Davidson, H.
    Holder, E.
    Davies, L. A.
    Pringle, I. A.
    Sumner-Jones, S. G.
    Baker, A.
    Tennant, P.
    Gordon, C.
    Vrettou, C.
    Blundell, R.
    Hyndman, L.
    Stevenson, B.
    Wilson, A.
    Doherty, A.
    Shaw, D. J.
    Coles, R. L.
    Painter, H.
    Cheng, S. H.
    Scheule, R. K.
    Davies, J. C.
    Innes, J. A.
    Hyde, S. C.
    Griesenbach, U.
    Alton, E. W. F. W.
    Boyd, A. C.
    Porteous, D. J.
    Gill, D. R.
    Collie, D. D. S.
    GENE THERAPY, 2011, 18 (10) : 996 - 1005
  • [7] Predictive Modeling of Non-Viral Gene Transfer
    Schwake, Gerlinde
    Youssef, Simon
    Kuhr, Jan-Timm
    Gude, Sebastian
    David, Maria Pamela
    Mendoza, Eduardo
    Frey, Erwin
    Raedler, Joachim O.
    BIOTECHNOLOGY AND BIOENGINEERING, 2010, 105 (04) : 805 - 813
  • [8] Ultrasound-assisted non-viral gene transfer to the salivary glands
    M J Passineau
    L Zourelias
    L Machen
    P C Edwards
    R L Benza
    Gene Therapy, 2010, 17 : 1318 - 1324
  • [9] Ultrasound-assisted non-viral gene transfer to the salivary glands
    Passineau, M. J.
    Zourelias, L.
    Machen, L.
    Edwards, P. C.
    Benza, R. L.
    GENE THERAPY, 2010, 17 (11) : 1318 - 1324
  • [10] Nucleocytoplasmic transport of DNA: enhancing non-viral gene transfer
    Wagstaff, Kylie M.
    Jans, David A.
    BIOCHEMICAL JOURNAL, 2007, 406 (02) : 185 - 202